Pfizer’s Lyrica fails in phase 3 trial in epilepsy patients with PGTC seizures

Image: Pfizer’s Lyrica could not meet the primary endpoint in a phase 3 trial in PGTC seizures. Photo: courtesy of Coolcaesar/Wikipedia.org.